What's different between Jack Ma, Alibaba and other Chinese companies? After all they and their government are cheaters. Only naive American investors believe in justice and fairness.
You're absolutely right. They'll start to cover or buy soon before twtr streams NFL in September 2016 and will upgrade twtr after 3rd quarter the same way like fb before. Don't be fool by unknown analysts. They work for brokers, investment banks not for investors.
No one cares about dead dog. But Wall Street talks about twtr every day and tries to lower its price. If they really think twtr is a dead dog why should they care about it?
The easy answer is they know twtr will go up big and soon and they try every thing to get twtr shares with cheap price. The smart investors shouldn't sell twtr. They'll get big reward soon.
Where is money for them to buy back stock?
Any way I wish it'll go up fast because I'm long. Good luck every body except shorts.
Sentiment: Strong Buy
Most of the time market overshoots because of investors's fear or greed plus crooks's scam.
Prgo went down irrationally too much by the same reason. We must be patient and the reward is on the way later.
Normally when a company has a new product or has another company who wants to buy out, its stock goes up. It's not the case of Perrigo. Do you think a change of CEO and a lower earnings makes a well established company such as Perrigo goes down from more than 205 to 95? The answer is NO.
So, the only explanation is this is a Wall Street scam to push the price down as far as possible then they can buy cheap shares. When they finish buying they will raise price or sell to Mylan with a huge profit.
I would like to remind you Perrigo is a well established company, founded in 1887 with 13,500 employees in Dublin, Ireland, not a company just IPO.
On April 6 2015 Mylan wanted to buy Perrigo at 29 Bil ($205/share) and Perrigo rejected because they said it's too low if compare to company value.
On April 27 2016 after ceo resigned and announcement of lower earnings, the price dropped to 97.50
What's a difference between a year, their value is cut more than a half.
Can any one explain why?
Because they're out of favor of Wall Street. Crooks want to keep price low until they load enough shares then they'll upgrade twtr.
This is the way crooks make money. They make every think that TWTR loses money loses customers and on the verge of bankruptcy. The fact is twtr still has profit and gains customers (of course not as high as the numbers they expected).
On another hand, some their favorite company such as goldman sach that lost 60% profit and its price is up.
Hang on and buy more because twtr will come back strongly soon.
First, ask yourself why did Mylan agree to pay 160/share last year and Perrigo fought tooth and nail to fend off the takeover? Is there a lot of change from last year in Perrigo beside its ceo leaves for Valeant? The bad earnings of this year happens with almost every companies. Why did Perrigo fall that hard?
I think this is WS crooks' trap to buy cheap shares from panic investors and after that they turn around and sell to Mylan at 160 easily. What's a golden opportunity for them!
How can valeant would be better?
During a couple of days Morgan Stanley manipulates price of 2 stocks when they have good news:
1. TWTR: 2 days ago when twtr got a contract of streaming Thursday NFL and price went up.
Instantly Brian Nowak, an analyst of Morgan Stanley downgraded twtr and gave TP between 8 -16. TWTR price was down badly in premarket but recovered and up again.
2. Today when ICPT got approved by FDA Advosory Committee 17/0 about OCA and icpt price advanced to 182 premarket. Again Morgan Stanley analyst Andrrew Berens downgraded icpt and lower TP from 100 to 80 that made icpt dropped from 182 to 147.53 in hour. ICPT was recovered a little ever since. I guess Morgan Stanley must hold a huge short position of icpt, so they has to do a dirty job like that.
With FDA approval I believe icpt will move up from now on despite the desperate effort to hold down its price by short sellers.
No. It'll open when the conclusion of the FDA Advisory Panel is reached.( recommand FDA to approve or require more data about OCA.)